• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia 
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

    View/Open
    Published version (437.9Kb)
    Published version (437.9Kb)
    Volume
    5
    DOI
    10.1038/bcj.2014.92
    Journal
    BLOOD CANCER JOURNAL
    ISSN
    2044-5385
    Metadata
    Show full item record
    Authors
    Farren, TW; Giustiniani, J; Fanous, M; Liu, F; Macey, MG; Wright, F; Prentice, A; Nathwani, A; Agrawal, SG
    URI
    http://www.nature.com/bcj/journal/v5/n1/full/bcj201492a.html
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7439
    Collections
    • Centre for Immunobiology [1029]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.